Colorectal cancer (CRC) is the third most common tumour in men and the second in women,
accounting for 10% of all tumour types worldwide. Incidence is 25% higher in males and …

The NCCN Clinical Practice Guidelines in Oncology for Colon Cancer begin with the clinical
presentation of the patient to the primary care physician or gastroenterologist and address …

Highlights•This article provides ESMO expert recommendations adapted for the treatment of
localised colon cancer in Asian patients.•The aim was to provide guidance for the …

Colorectal cancer (CRC) is the third most common tumour in men and the second in women,
accounting for 10% of all tumour types worldwide. Incidence is higher in males (ratio: 1.4) …

Colorectal cancer is the fourth most frequently diagnosed cancer and the second leading
cause of cancer death in the United States. In 2011, an estimated 101,340 new cases of …

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

In 2006 there were 412 900 new cases of colorectal cancer in Europe. This is 12.9% of all
cancer cases. Colorectal cancer was responsible for 217 400 deaths in Europe in 2006. This …

Cancers of the colon and rectum altogether are the third most common tumour type
worldwide. Cancer of the colon is more frequent than rectal cancer: in high-risk populations …

Staging provides essential prognostic information relevant for choosing adequate therapy
and should also identify patients with resectable distant metastases. Preoperative staging …

Colorectal cancer (CRC) is the most common tumour type in both sexes combined in
Western countries. Although screening programmes including the implementation of faecal …